Blended learning for entrepreneurial biomedical professionals
Paul Janssen Futurelab Leiden offers a non-profit, international blended learning program for tomorrow’s leaders in biomedical science who have the ambition to develop a new medical intervention.
Featured course
Featured resource
Featured
white paper
Take the next step in your biomedical career
Do you have a great idea for a new medical product, but no idea where to start developing it? The trick is to find a post-graduate training program that is suited to your specific needs.
That's why we wrote a white paper about the Future4 approach to help you find the right post-graduate program by identifying the four key focus areas that will take your career to the next level.
Get access to our white paper

On-campus experience
Further explore the concepts of the online courses during the on-campus course. Maximum 30 participants are invited to castle Oud-Poelgeest near Leiden, the Netherlands to work in small, multidisciplinary focus groups on advanced teaching cases that are based on real R&D project.
Read more
A selection of our contributors

Juliane Bernholz
Chief Operating Officer
AM Pharma

Onno van de Stolpe
CEO
Galapagos B.V.

Marc Martens
Head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels
Bird & Bird

Aliki Nichogiannopoulou
Director
European Patent Office

Ton van der Hoven
CEO
SurgVision BV

Bruno Vandermeulen
IP Lawyer - Member of the Brussels Bar
Independent IP practitioner
On-campus

Nacer Lounis
Senior Principal Scientist
Janssen Pharmaceutica
On-campus

Tine de Marez
Senior Director, Compound Development Team Leader TB
Johnson & Johnson

Bert Leufkens
Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board
Utrecht Institute for Pharmaceutical Sciences (UIPS)

Henk Schuring
VP-Head Rare Nephrology
Sanofi Genzyme

Sjaak Bot
VP, Head of EMEA Regulatory Affairs
Janssen

Bernd van der Meulen
Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School

Frank Landolt
Chief Counsel Legal & Intellectual Property
Confo Therapeutics
On-campus

Erik Niks
Neurologist - Pediatric neurologist
Leiden University Medical Center
On-campus

Piet Hinoul
Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon
On-campus

Ad Sitsen
Owner
ClinPharMed Consultancy for Drug Development

Eline Bunnik
Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC

Maurits Westerik
IE/IT lawyer
Coupry

Bart Swinkels
Partner
NLO

Karin Verzijden
Food and Pharma Lawyer
Axon Lawyers
On-campus

Ineke Jonker-Hoogerkamp
Consultant Regulatory Affairs and Drug Development
Paul Janssen Futurelab & Eagle Pharma Consult

Kees Recourt
Investment Manager
Mibiton Foundation

Paul Stoffels
Chief scientific officer
Johnson & Johnson

Tom Huizinga
Head of the Department of Rheumatology
Leiden University Medical Centre
On-campus

Marcel Kenter
Director
Paul Janssen Futurelab Leiden
On-campus

Koen Andries
VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV
On-campus

Andreas Wallnöfer
General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)
On-campus

Justin Hay
Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency
On-campus

André Elferink
Clinical epidemiologist
Dutch Medicines Evaluation Board
On-campus

Rob Zuiker
Senior Clinical Scientist
CHDR

Hans-Georg Eichler
Senior Medical Officer
European Medicines Agency
On-campus

Robert Klautz
Thoracic Surgeon
Leiden University Medical Centre
On-campus

Matthijs Moerland
Research Director Translational Biomarkers
CHDR

Joris Rotmans, MD, PhD
internist-nephrologist
LUMC
On-campus

Janneke Meulenberg
CEO
Arthrogen

Inge de Lepeleire
Director Translational Pharmacology
MSD Europe
On-campus

Koos Burggraaf
Research Director CVS & Metabolism
CHDR

Johan Garssen
Director Immunology Platform
Danone/Nutricia Research
On-campus

Ingrid de Visser
Senior Clinical Scientist
CHDR

Rick Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic
On-campus

Geert Jan Groeneveld
Research Director CNS
CHDR

Oliver Bisazza
Director Regulatory Policy
Medtronic

Saco de Visser
Teacher and Clinical Pharmacologist
Paul Janssen Futurelab Leiden
On-campus

Adam Cohen
CEO and clinical pharmacologist
Centre for Human Drug Research

Richard Shull
Head of Deal Structuring and Trading Fundamentals
Shell

Pierre Peeters
Former site head early stage development
Organon

Genuinely fascinating
The case studies were all thought provoking, well-chosen and expertly presented to make different points. Genuinely fascinating: thanks!
Huw Lewis, GlaxoSmithKline Clinical Development Online graduate

Real life cases
The interactive program of the course ensures that you easily understand the information and make it applicable. The real life cases make this course interesting for biomedical professionals.
Laurel van Schunselaar, LUMC, postdoctoral researcher/ clinical study coordinator

Happy with responses
“Real life case studies and learning about 'how it really happened'. Very happy with responses on comments (timewise and content)”
Joost van Middendorp, Pfizer, Clinical Development Online graduate

Excellent course for professionals
Excellent course for professionals planning to work with patents and/or license agreements. Offers top-level interviews that provide a general view of patent management and goes into practical steps with actual use of websites, tools, and a generous amount of examples.
Ernest Spitzer, European Cardiovascular Research Institute